Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease

Author： Karlsson R.-M.   Holmes A.  

Publisher： Springer Publishing Company

ISSN： 0939-4451

Source： Amino Acids, Vol.31, Iss.3, 2006-10, pp. : 231-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NAD+ metabolism: A therapeutic target for age-related metabolic disease

By Mouchiroud Laurent   Houtkooper Riekelt H.   Auwerx Johan  

Critical Reviews in Biochemistry and Molecular Biology, Vol. 48, Iss. 4, 2013-07 ,pp. : 397-408

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptides in anxiety and depression

By Landgraf R.  

Amino Acids, Vol. 31, Iss. 3, 2006-10 ,pp. : 211-213

Springer Publishing Company

Access to resources Recommend Favorite

TTD: Therapeutic Target Database

By Chen X.   Ji Z.L.   Chen Y.Z.  

Nucleic Acids Research, Vol. 30, Iss. 1, 2002-01 ,pp. : 412-415

Oxford University Press

Access to resources Recommend Favorite

PRAS40: Target or modulator of mTORC1 signalling and insulin action?

By Nascimento Emmani   Ouwens D. Margriet  

Archives of Physiology and Biochemistry, Vol. 115, Iss. 4, 2009-10 ,pp. : 163-175

Informa Healthcare

Access to resources Recommend Favorite

STAT3 as a therapeutic target in head and neck cancer

By Leeman Rebecca J   Lui Vivian Wai Yan   Grandis Jennifer Rubin  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 231-241

Informa Healthcare

Access to resources Recommend Favorite